secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kenvue Inc. (KVUE)
CIK:        0001944048
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001944048-24-000136
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kenvue Q2 adjusted EPS $0.32, organic sales +1.5%; reaffirms FY24 outlook
-------------------------------------------------------------------------

- Net sales $4.0B, down 0.3% YoY; organic growth +1.5% (value realization +2.1%, volume -0.6%).
- Diluted EPS $0.03; adjusted diluted EPS $0.32 vs $0.31 prior year; adjusted operating margin 22.8% vs 23.1%.
- Non-cash impairment charge of $488M ($337M after-tax) on Dr.Ci:Labo assets due to China market dynamics.
- FY24 outlook reaffirmed: net sales growth 1%-3%, organic growth 2%-4%, adjusted EPS $1.10-$1.20.
- Gross profit margin expanded 360 bps to 59.1%; adjusted gross margin expanded 410 bps to 61.6%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1944048/000194404824000136/0001944048-24-000136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1944048/000194404824000136/kvue-20240806.htm
  HTML page:      https://secwatch.observer/filing/0001944048-24-000136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer